Guardian Pharmacy Services, Inc. (GRDN)
NYSE: GRDN · Retail-Drug Stores and Proprietary Stores · Atlanta, GA · filing with the SEC since 2020
Who owns Guardian Pharmacy Services, Inc.
As filed with the SECHolders of 5% or more
2
Thomas J. Salentine, Jr. holds 26.4% of Class A Common Stock, par value $0.001 per share, as its SCHEDULE 13D/A filed Sep 28, 2026 says.
Directors and officers
16
report now, of 16 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Thomas J. Salentine, Jr.
SCHEDULE 13D/A · filed Sep 28, 2026 · Class A Common Stock, par value $0.001 per share · 21.3% in Mar 24, 2026
Fmr LLC
SCHEDULE 13G · filed May 6, 2026 · CLASS A COMMON STOCK
Alyeska Investment Group, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Class A Common Stock, par value $0.001 per share · reported falling below 5%
Brown Advisory Inc
SCHEDULE 13G/A · filed Feb 13, 2026 · Class A Common Stock, par value $0.001 per share · reported falling below 5%, from 7.1% in Apr 22, 2025
Woodline Partners LP
SCHEDULE 13G/A · filed Feb 14, 2025 · Class A Common Stock, par value $0.001 per share · reported falling below 5%
Franklin Resources, Inc.
SCHEDULE 13G/A · filed Aug 5, 2025 · Class A Common Stock, par value $0.001 per share · reported falling below 5%, from 8% in May 9, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Jul 29, 2025 · Common Stock · reported falling below 5%, from 6.5% in Jan 30, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Jan 21, 2026 · Class A Stock · reported falling below 5%, from 5.7% in Oct 17, 2025
Wellington Management Group LLP
SCHEDULE 13G/A · filed Feb 10, 2026 · Common Stock · reported falling below 5%, from 5% in Nov 12, 2025
J. Goldman & Co LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock · reported falling below 5%, from 8.2% in Nov 14, 2024
TIAA-CREF Investment Management, LLC
SCHEDULE 13G/A · filed Jun 6, 2025 · Common Stock · reported falling below 5%
Clearbridge Investments, LLC
SCHEDULE 13G/A · filed Aug 5, 2025 · Class A Common Stock, par value $0.001 per share · reported falling below 5%, from 5.6% in May 9, 2025
Ophir Asset Management Pty Ltd
SCHEDULE 13G/A · filed Jan 2, 2025 · Class A Ordinary Shares · reported falling below 5%
Nuveen Asset Management, LLC
SCHEDULE 13G/A · filed Jun 6, 2025 · Common Stock · reported falling below 5%
Teachers Advisors, LLC
SCHEDULE 13G/A · filed Jun 6, 2025 · Common Stock · reported falling below 5%
What GRDN reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Pharmacy Operations
A company bought · acquisition · owns, named in the 10-K filed Mar 11, 2026
54 subsidiaries in 1 country, from the list filed with the 10-K filed Mar 11, 2026.
Insider tradesForm 4
7sales
1purchases
0sales on a scheduled plan
6people selling
$281Msold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window10 of 19 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bindley William E | director | 1 | $106M | 0 | 0 | $0 |
| Salentine Thomas J Jr | director | 1 | $106M | 0 | 0 | $0 |
| Bindley Capital Partners I, LLC | 10% owner | 1 | $106M | 0 | 0 | $0 |
| Ackerman John | director | 2 | $32.7M | 0 | 0 | $0 |
| Pharmacy Investors, LLC | other | 1 | $24.6M | 0 | 0 | $0 |
| Burke Fred | President and Chief Executive Officer | 1 | $19.9M | 0 | 0 | $0 |
| Forbes Kendall | Executive Vice President, Sales & Operations | 1 | $10.3M | 0 | 0 | $0 |
| Cardinal Equity Fund, L.P. | other | 1 | $8.2M | 0 | 0 | $0 |
| Morris David K | Executive Vice President, Chief Operating Officer | 1 | $5.6M | 0 | 0 | $0 |
| Cosler Steven D | director | 0 | $0 | 0 | 1 | $100,000 |